GRAFTYS strengthens its management and operations

OREGA presents its first-in-class CD39 checkpoint inhibitor at the AACR meeting
19 April 2016
Four projects supported by our foundation
5 February 2016

GRAFTYS strengthens its management and operations

Gilles Alberici, Chairman of the Board, will serve as Chief Executive Officer.